Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease

11 Mar 2024

Abstract excerpt

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global epidemic and is the most rapidly rising cause of HCC. Clonal hematopoiesis of indeterminate potential (CHIP) contributes to neoplastic and cardiometabolic disorders and is considered a harbinger of tissue inflammation. CHIP was recently associated with increased risk of liver disease. The aim of this study was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Mitochondrial Function and Pathology
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38470216
DOI: 10.1097/hep.0000000000000839

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseasePMID 38470216Read ↗

Clonal Hematopoiesis and the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read ↗

Clonal hematopoiesis and risk of chronic liver diseaseSemantic proximity Read ↗

Clonal hematopoiesis of indeterminate potential and risk of hepatocellular carcinoma: New kids on the blockSemantic proximity Read ↗

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in population with MASLDSemantic proximity Read ↗

Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives.Semantic proximity Read ↗

Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases.Semantic proximity Read ↗

Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.Semantic proximity Read ↗

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.Semantic proximity Read ↗

Clonal hematopoiesis of indeterminate potential: a unifying mechanism linking metainflammation and cardiometabolic diseases.Semantic proximity Read ↗

Germline mutations and somatic mosaicism in steatotic liver diseases and related liver carcinogenesis.Semantic proximity Read ↗

Clonal hematopoiesis of indeterminate potential and risk of immune thrombocytopenia.Semantic proximity Read ↗

Clonal Hematopoiesis of Indeterminate Potential Refines Cardiovascular Risk Stratification in Cardiovascular-Kidney-Metabolic Syndrome Stages 0–3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.